G0S2 and chronic myelogenous leukemia, BCR-ABL1 positive: While CML patients with kinase‐independent TKI resistance had reduced G0S2 expression compared with normal CB, there was no significant difference compared with CP‐CML or BP‐CML patients (Figure 1A).